Ceresti Health opens a Medicare GUIDE wait list enabling family caregivers nationwide to access tech-enabled dementia care under CMS's new Medicare program launching July 2025. No cost to patients or caregivers.

ASTRO backs bipartisan legislation to reform Medicare Advantage prior authorization, aiming to reduce cancer treatment delays and improve care outcomes.

HHS and CMS unveil Most Favored Nation drug pricing model targeting pharmaceutical manufacturers to align U.S. drug prices with international benchmarks and reduce costs.

The DOJ files a lawsuit accusing insurers and brokerages of illicit kickbacks in Medicare Advantage plan enrollments, raising compliance and regulatory concerns.

UnitedHealthcare stops paying commissions on Medicare prescription drug plans sold after June 1, 2025, impacting agents amid rising Medicare Advantage costs and prompting calls for CMS intervention.

Bipartisan legislation aims to cap Medicare coinsurance costs for services at ambulatory surgical centers, promoting cost-effective healthcare and reducing patient expenses.

CMS Administrator Dr. Mehmet Oz emphasizes protecting Medicare and Medicaid beneficiaries, targeting fraud, waste, and abuse, and promoting healthy living initiatives under new CMS leadership.

UnitedHealth’s stock rebounds amid DOJ probe and leadership stock purchases, reflecting market dynamics in healthcare, regulatory challenges, and sector shifts.

Explore how proposed $880B federal cuts to Medicaid and Medicare could reduce coverage for millions, affecting quality of care and access to critical health services across the U.S.

Explore critical regulatory updates and compliance strategies for healthcare providers navigating evolving vaccine policies and Medicare billing rules. Learn from expert legal and clinical insights to manage outbreak risks and optimize revenue cycle operations.